title: Novel agents for the treatment of childhood acute leukemia.
abstract: Together, acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) make up approximately one-third of all pediatric cancer diagnoses. Despite remarkable improvement in the treatment outcomes of these diseases over the past several decades, the prognosis for certain high-risk groups of leukemia and for relapsed disease remains poor. However, recent insights into different types of 'driver' lesions of leukemogenesis, such as the aberrant activation of signaling pathways and various epigenetic modifications, have led to the discovery of novel agents that specifically target the mechanism of transformation. In parallel, emerging approaches in cancer immunotherapy have led to newer therapies that can exploit and harness cytotoxic immunity directed against malignant cells. This review details the rationale and implementation of recent and specifically targeted therapies in acute pediatric leukemia. Topics covered include the inhibition of critical cell signaling pathways [BCR-ABL, FMS-like tyrosine kinase 3 (FLT3), mammalian target of rapamycin (mTOR), and Janus-associated kinase (JAK)], proteasome inhibition, inhibition of epigenetic regulators of gene expression [DNA methyltransferase (DNMT) inhibitors, histone deacetylase (HDAC) inhibitors, and disruptor of telomeric signaling-1 (DOT1L) inhibitors], monoclonal antibodies and immunoconjugated toxins, bispecific T-cell engaging (BiTE) antibodies, and chimeric antigen receptor-modified (CAR) T cells.
authors.affiliation: Oncology and Pediatrics, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
authors.forename: Colleen E
authors.initials: CE
authors.lastname: Annesley
authors.affiliation: Oncology and Pediatrics, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, CRB-I 2M46, Baltimore, MD 21231, USA.
authors.forename: Patrick
authors.initials: P
authors.lastname: Brown
keywords: ALL; AML; CAR T-cells; EPZ-5676; FLT3; blinatumomab; carfilzomib; moxetumomab
references.citation: Clin Cancer Res. 2010 Mar 15;16(6):1894-903
references.pmid: 20215554
references.citation: Science. 1996 Nov 1;274(5288):784-7
references.pmid: 8864119
references.citation: Cancer. 2014 Apr 1;120(7):1002-9
references.pmid: 24382642
references.citation: N Engl J Med. 2013 Nov 7;369(19):1783-96
references.pmid: 24180494
references.citation: Klin Padiatr. 2006 Nov-Dec;218(6):327-33
references.pmid: 17080335
references.citation: Oncogene. 1999 Nov 25;18(50):7016-25
references.pmid: 10597302
references.citation: Med Pediatr Oncol. 1999 Dec;33(6):525-9
references.pmid: 10573574
references.citation: Cell. 2005 Apr 22;121(2):167-78
references.pmid: 15851025
references.citation: Br J Haematol. 2012 May;157(4):507-10
references.pmid: 22299775
references.citation: Blood. 2013 Mar 28;121(13):2533-41
references.pmid: 23361907
references.citation: J Clin Oncol. 2002 May 15;20(10):2429-40
references.pmid: 12011120
references.citation: Blood. 2008 Aug 15;112(4):1005-12
references.pmid: 18477770
references.citation: Clin Cancer Res. 2000 Apr;6(4):1476-87
references.pmid: 10778980
references.citation: Cancer. 2013 Aug 1;119(15):2728-36
references.pmid: 23633004
references.citation: Blood. 2007 Dec 15;110(13):4445-54
references.pmid: 17855633
references.citation: Cancer Res. 1993 Jul 15;53(14):3336-42
references.pmid: 8324745
references.citation: J Clin Oncol. 2012 May 10;30(14):1663-9
references.pmid: 22412151
references.citation: Oncogene. 2001 Sep 10;20(40):5695-707
references.pmid: 11607819
references.citation: Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3982S-90S
references.pmid: 14506197
references.citation: Cancer Cell. 2006 Oct;10(4):331-42
references.pmid: 17010674
references.citation: Leukemia. 2003 May;17(5):995-7
references.pmid: 12750723
references.citation: Cancer Cell. 2011 Jul 12;20(1):66-78
references.pmid: 21741597
references.citation: Blood. 2003 Aug 1;102(3):972-80
references.pmid: 12702506
references.citation: Blood. 2005 Mar 15;105(6):2527-34
references.pmid: 15550488
references.citation: Blood. 2008 Sep 1;112(5):2020-3
references.pmid: 18544682
references.citation: Blood. 2010 Oct 21;116(16):3013-22
references.pmid: 20647567
references.citation: Cancer Cell. 2011 Jul 12;20(1):53-65
references.pmid: 21741596
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):7042-7
references.pmid: 20348416
references.citation: Blood. 2012 Oct 25;120(17):3510-8
references.pmid: 22955920
references.citation: Blood. 2001 Jan 1;97(1):89-94
references.pmid: 11133746
references.citation: Leukemia. 2010 Aug;24(8):1437-44
references.pmid: 20535150
references.citation: Mol Cancer Ther. 2008 Sep;7(9):2998-3005
references.pmid: 18790780
references.citation: Clin Cancer Res. 2005 Oct 1;11(19 Pt 2):7164s-7170s
references.pmid: 16203817
references.citation: Blood. 2012 Oct 4;120(14):2817-25
references.pmid: 22833546
references.citation: Leuk Lymphoma. 2014 Jul;55(7):1652-3
references.pmid: 24024475
references.citation: Leukemia. 2011 Jan;25(1):181-4
references.pmid: 20944674
references.citation: Sci Transl Med. 2011 Aug 10;3(95):95ra73
references.pmid: 21832238
references.citation: J Clin Oncol. 2010 Aug 1;28(22):3623-9
references.pmid: 20606092
references.citation: J Clin Oncol. 2010 Apr 10;28(11):1856-62
references.pmid: 20212254
references.citation: Pediatr Blood Cancer. 2010 Aug;55(2):254-9
references.pmid: 20582937
references.citation: Blood. 2000 Mar 15;95(6):2098-103
references.pmid: 10706880
references.citation: Cancer Cell. 2010 Feb 17;17(2):198-212
references.pmid: 20153263
references.citation: Blood. 2006 Nov 15;108(10):3262-70
references.pmid: 16857985
references.citation: Leukemia. 2014 Jul;28(7):1467-71
references.pmid: 24441288
references.citation: Cancer Res. 2010 Dec 15;70(24):10234-42
references.pmid: 21159644
references.citation: Proc Natl Acad Sci U S A. 2012 May 1;109(18):6898-903
references.pmid: 22509046
references.citation: Clin Cancer Res. 2008 Mar 1;14(5):1446-54
references.pmid: 18316568
references.citation: Blood. 2006 Dec 1;108(12):3654-61
references.pmid: 16912228
references.citation: Cancer. 2012 Feb 1;118(3):761-9
references.pmid: 21766293
references.citation: J Clin Oncol. 2011 Feb 1;29(4):369-77
references.pmid: 21172891
references.citation: Clin Cancer Res. 2006 Sep 1;12(17):5165-73
references.pmid: 16951235
references.citation: J Biol Chem. 2002 Aug 23;277(34):30421-4
references.pmid: 12097318
references.citation: Blood. 2004 May 15;103(10):3669-76
references.pmid: 14726387
references.citation: Cancer. 2006 Apr 15;106(8):1794-803
references.pmid: 16532500
references.citation: Blood. 1999 Jun 1;93(11):3678-84
references.pmid: 10339474
references.citation: Blood. 2001 Apr 15;97(8):2434-9
references.pmid: 11290608
references.citation: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):16220-5
references.pmid: 12451177
references.citation: Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15113-8
references.pmid: 14657335
references.citation: Blood. 2013 Oct 31;122(18):3122-8
references.pmid: 24014245
references.citation: J Clin Oncol. 2011 Feb 10;29(5):551-65
references.pmid: 21220611
references.citation: J Clin Oncol. 2013 Feb 10;31(5):573-83
references.pmid: 23295790
references.citation: Cancer Res. 2001 Mar 15;61(6):2558-61
references.pmid: 11289131
references.citation: Curr Cancer Drug Targets. 2021;21(9):804-811
references.pmid: 33949932
references.citation: Blood. 2008 Dec 15;112(13):4839-42
references.pmid: 18818391
references.citation: J Clin Oncol. 2001 Jul 1;19(13):3244-54
references.pmid: 11432892
references.citation: Science. 2008 Aug 15;321(5891):974-7
references.pmid: 18703743
references.citation: Leukemia. 2003 Jan;17(1):83-8
references.pmid: 12529664
references.citation: Clin Cancer Res. 2011 May 1;17(9):2734-43
references.pmid: 21364033
references.citation: Br J Haematol. 2010 Aug;150(3):352-8
references.pmid: 20528877
references.citation: Leuk Lymphoma. 2010 Feb;51(2):252-60
references.pmid: 20109071
references.citation: Blood. 2014 Mar 27;123(13):2017-25
references.pmid: 24497539
references.citation: Nat Clin Pract Oncol. 2005 Dec;2 Suppl 1:S30-5
references.pmid: 16341238
references.citation: Proc Natl Acad Sci U S A. 1984 Nov;81(22):6993-7
references.pmid: 6209710
references.citation: FASEB J. 2008 May;22(5):1369-79
references.pmid: 18073335
references.citation: Blood. 2009 Sep 24;114(13):2764-73
references.pmid: 19546476
references.citation: Leukemia. 2007 Nov;21(11):2240-5
references.pmid: 17657218
references.citation: Cancer Res. 2006 Jun 15;66(12):6361-9
references.pmid: 16778214
references.citation: Hematology. 2012 Apr;17 Suppl 1:S59-62
references.pmid: 22507781
references.citation: Leukemia. 2010 Mar;24(3):552-62
references.pmid: 20072153
references.citation: Pediatr Blood Cancer. 2014 Feb;61(2):369-72
references.pmid: 24000241
references.citation: Blood. 2012 Aug 2;120(5):978-84
references.pmid: 22730539
references.citation: Science. 1988 May 27;240(4856):1198-201
references.pmid: 3240341
references.citation: Clin Cancer Res. 2007 Mar 1;13(5):1516-22
references.pmid: 17332297
references.citation: Blood. 1995 Oct 15;86(8):3097-108
references.pmid: 7579404
references.citation: Blood. 2005 Jan 1;105(1):54-60
references.pmid: 15345597
references.citation: J Clin Oncol. 2010 Oct 1;28(28):4339-45
references.pmid: 20733134
references.citation: Cancer Res. 1997 Mar 1;57(5):837-41
references.pmid: 9041182
references.citation: Cancer Cell. 2008 Nov 4;14(5):355-68
references.pmid: 18977325
references.citation: Blood. 2007 Oct 1;110(7):2302-8
references.pmid: 17596541
references.citation: Blood. 2011 Mar 24;117(12):3294-301
references.pmid: 21270442
references.citation: J Biol Chem. 2006 Jun 30;281(26):18059-68
references.pmid: 16636056
references.citation: Cell Cycle. 2005 Nov;4(11):1540-9
references.pmid: 16205124
references.citation: Blood. 2013 Feb 14;121(7):1165-74
references.pmid: 23243285
references.citation: J Clin Oncol. 2012 Nov 10;30(32):3921-3
references.pmid: 22987091
references.citation: Nature. 2006 Aug 17;442(7104):818-22
references.pmid: 16862118
references.citation: Nat Rev Cancer. 2006 Jul;6(7):559-65
references.pmid: 16794638
references.citation: J Natl Cancer Inst. 2008 Feb 6;100(3):184-98
references.pmid: 18230792
references.citation: Cancer. 2013 Nov 15;119(22):4036-43
references.pmid: 24006085
references.citation: Annu Rev Med. 2014;65:333-47
references.pmid: 24274181
references.citation: Leukemia. 2012 Apr;26(4):682-92
references.pmid: 22015773
references.citation: Lancet. 2010 Dec 11;376(9757):2009-17
references.pmid: 21131038
references.citation: J Clin Oncol. 2005 Jan 20;23(3):630-9
references.pmid: 15659509
references.citation: J Clin Oncol. 2011 Aug 20;29(24):3293-300
references.pmid: 21768474
references.citation: Cancer Res. 2006 Mar 1;66(5):2794-800
references.pmid: 16510601
references.citation: Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9414-8
references.pmid: 19470474
references.citation: Lancet. 2012 Apr 21;379(9825):1508-16
references.pmid: 22482940
references.citation: Nat Genet. 2002 Jan;30(1):41-7
references.pmid: 11731795
references.citation: Drug Metab Dispos. 2011 Oct;39(10):1873-82
references.pmid: 21752943
references.citation: Blood. 2006 Nov 15;108(10):3271-9
references.pmid: 16882711
references.citation: Blood. 2008 Aug 15;112(4):981-9
references.pmid: 18495956
references.citation: J Clin Oncol. 2011 Jun 20;29(18):2493-8
references.pmid: 21576633
references.citation: Blood. 2012 Jul 12;120(2):285-90
references.pmid: 22653976
references.citation: Lancet Oncol. 2010 Jun;11(6):543-52
references.pmid: 20451454
references.citation: Leukemia. 1999 Jan;13(1):38-43
references.pmid: 10049058
references.citation: Semin Hematol. 2004 Apr;41(2 Suppl 4):27-32
references.pmid: 15190513
references.citation: Blood. 2012 Dec 20;120(26):5185-7
references.pmid: 23024237
references.citation: Nat Rev Clin Oncol. 2011 Jun 28;8(9):540-9
references.pmid: 21709698
references.citation: Lancet Oncol. 2012 Apr;13(4):403-11
references.pmid: 22357140
references.citation: N Engl J Med. 2006 Jun 15;354(24):2531-41
references.pmid: 16775234
references.citation: Leukemia. 2012 Oct;26(10):2233-44
references.pmid: 22469781
references.citation: J Clin Oncol. 2010 Apr 20;28(12):2085-93
references.pmid: 20308665
references.citation: Blood. 2011 Jun 23;117(25):6912-22
references.pmid: 21521783
references.citation: Blood. 2004 Mar 1;103(5):1807-14
references.pmid: 14615373
references.citation: N Engl J Med. 2013 Apr 18;368(16):1509-1518
references.pmid: 23527958
references.citation: Cancer Res. 1989 Sep 1;49(17):4906-12
references.pmid: 2667754
references.citation: Biol Blood Marrow Transplant. 2012 Feb;18(2):324-9
references.pmid: 22079471
references.citation: Blood. 2012 Jun 28;119(26):6226-33
references.pmid: 22592608
references.citation: Blood. 2012 May 31;119(22):5201-10
references.pmid: 22496163
references.citation: Cancer Res. 2003 Aug 15;63(16):4882-7
references.pmid: 12941810
references.citation: PLoS One. 2010 Jun 03;5(6):e10941
references.pmid: 20532179
references.citation: Leukemia. 2013 Apr;27(4):813-22
references.pmid: 23138183
references.citation: Blood. 2001 Oct 15;98(8):2301-7
references.pmid: 11588023
references.citation: J Clin Oncol. 2009 Nov 1;27(31):5175-81
references.pmid: 19805687
references.citation: Blood. 1996 Feb 1;87(3):1089-96
references.pmid: 8562934
references.citation: N Engl J Med. 2014 Sep 11;371(11):1005-15
references.pmid: 25207766
references.citation: Proc Natl Acad Sci U S A. 1994 Jan 18;91(2):459-63
references.pmid: 7507245